Resmed (RMD) Leases (2019 - 2026)

Resmed (RMD) has 8 years of Leases data on file, last reported at $161.6 million in Q1 2026.

• For the quarter ending Q1 2026, Leases rose 5.9% year-over-year to $161.6 million; the trailing twelve-month figure through Mar 2026 stood at $161.6 million (up 5.9% YoY), and the FY2025 full-year result was $167.5 million, up 10.84% from the prior year.
• Leases for Q1 2026 stood at $161.6 million, down from $165.9 million in the prior quarter.
• Across five years, Leases topped out at $167.5 million in Q2 2025 and bottomed at $123.4 million in Q3 2023.
• The 5-year median for Leases is $151.0 million (2024), against an average of $145.6 million.
• The widest annual swing landed in 2022, when Leases dropped 12.2%; it then gained 27.27% in 2024.
• A 5-year view of Leases shows it stood at $128.2 million in 2022, then rose by 19.69% to $153.5 million in 2023, then declined by 1.6% to $151.0 million in 2024, then increased by 9.87% to $165.9 million in 2025, then fell by 2.6% to $161.6 million in 2026.
• The last three Leases figures came in at $161.6 million (Q1 2026), $165.9 million (Q4 2025), and $162.0 million (Q3 2025), per Business Quant data.

Peer Comparison